Latest news

Sionna Therapeutics Targets $156 Million in IPO to Advance Cystic Fibrosis Research

Sionna Therapeutics, a biotechnology firm headquartered in Waltham, Massachusetts, is preparing to raise up to $156 million through an...

AdvanCell Bags $112M in Series C Funding For Alpha Radiopharma Trial

AdvanCell has raised $112 million in a Series C fundraising round supported by Sanofi Ventures. The Australian radiopharmaceutical firm...

Atalanta Therapeutics Secures $97 Million to Advance siRNA Therapies for Neurological Disorders

Atalanta Therapeutics has raised $97 million in a successful Series B financing round, which will support the initiation of...

Leap Therapeutics Shifts Focus to Colorectal Cancer After Mixed Phase 2b Trial Results

Leap Therapeutics has decided to redirect its efforts towards colorectal cancer following mixed results from a midstage trial of...

AZ, Daiichi’s Enhertu Bags 7th FDA Green Light, First For Breast Cancer

Enhertu, the first antibody-drug conjugate (ADC) developed by AstraZeneca...

InnoCare and Keymed License Ex-China Rights for Bispecific to RTW-Backed Biotech in $520M Agreement

Chinese biotechs InnoCare Pharma and KeyMed Biosciences have licensed...

Disc Medicine Refines Trial Design for EPP Drug, Targets Accelerated FDA Approval

Disc Medicine has finalized the design for its confirmatory trial of bitopertin, a drug candidate aimed at addressing a...

Failed facility inspection by partners places Atara’s Ebvallo pipeline candidate on clinical hold in the United States

Atara Biotherapeutics has now faced a second setback after getting a complete response from the FDA through its T-cell...

Life Sciences Voice Top Five Newsletter

Welcome to this week’s edition of the Life Sciences Voice Top Five Newsletter, your go-to source for the latest...

Regenxbio And Nippon Sinyaku Pen $810M Gene Therapy Agreement

Regenxbio has struck a strategic partnership valued at $810...

Sling Therapeutics Challenges Tepezza in Thyroid Eye Disease Treatment

Sling Therapeutics has achieved a milestone in the development...

Umoja Biopharma Secures $100 Million Series C Funding for Cell Therapy Advancements

Umoja Biopharma has successfully closed a $100 million Series C funding round, marking a step forward for the company’s...

J&J’s Lung Cancer Combo Outperforms Tagrisso in Survival Rates

Johnson & Johnson has achieved a breakthrough in the treatment of non-small cell lung cancer (NSCLC), with its combination...

Merck’s HPV Vaccine Gets Green Light From China Regulator

According to a statement released by Merck, its human papillomavirus vaccination (HPV) has been authorized for male use in...

AdvanCell Bags $112M in Series C Funding For Alpha Radiopharma Trial

AdvanCell has raised $112 million in a Series C...

Merck to Acquire Harpoon Therapeutics In a Deal Worth $680M

With the agreement to shell out $680...

Biopharma company GBT acquired by Pfizer in a $5.4B agreement

A conclusive agreement has been signed by...

Popular

Most popular life news you must read today

NRx Pharma’s ZYESAMI™ approved for emergency use Covid critical care in Georgia

As of July 27, a global biopharmaceutical company, NRx Pharmaceuticals, has announced that the Prime Minister of the Nation of Georgia

A Patient Centric Approach to Clinical Research is Key for Product Development

Ensuring a patient centric approach during clinical...

Commercial

AdvanCell Bags $112M in Series C Funding For Alpha Radiopharma Trial

AdvanCell has raised $112 million in a Series C fundraising round supported by Sanofi Ventures. The Australian radiopharmaceutical firm...

Atalanta Therapeutics Secures $97 Million to Advance siRNA Therapies for Neurological Disorders

Atalanta Therapeutics has raised $97 million in a successful Series B financing round, which will support the initiation of...

Versant introduces another obesity biotech with “clinic-ready” GIP antibody and a $65M Series A

Versant Ventures established Helicore Biopharma exactly two months after establishing Pep2Tango Therapeutics as its second obesity-centered biotechnology startup.Helicore Biopharma...

Regenxbio And Nippon Sinyaku Pen $810M Gene Therapy Agreement

Regenxbio has struck a strategic partnership valued at $810 million with Japan's Nippon Shinyaku to promote gene treatments aimed...

Umoja Biopharma Secures $100 Million Series C Funding for Cell Therapy Advancements

Umoja Biopharma has successfully closed a $100 million Series C funding round, marking a step forward for the company’s...

Tune Therapeutics Raises Whopping $175M to Bring Epigenetic Drug Into Clinic

Investors are clearly in no doubt over the functionality of Tune Therapeutics’ epigenetic silencing drug, providing the biotech with...

Information Technology

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...

Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient

Neuralink, founded by Elon Musk, revealed that it has placed its device in the...

AI Firm Formation Bags $372 Series D Funding

In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure...

Regulatory

AZ, Daiichi’s Enhertu Bags 7th FDA Green Light, First For Breast Cancer

Enhertu, the first antibody-drug conjugate (ADC) developed by AstraZeneca...

AdvanCell Bags $112M in Series C Funding For Alpha Radiopharma Trial

AdvanCell has raised $112 million in a Series C...

Atalanta Therapeutics Secures $97 Million to Advance siRNA Therapies for Neurological Disorders

Atalanta Therapeutics has raised $97 million in a successful...

Leap Therapeutics Shifts Focus to Colorectal Cancer After Mixed Phase 2b Trial Results

Leap Therapeutics has decided to redirect its efforts towards...

Versant introduces another obesity biotech with “clinic-ready” GIP antibody and a $65M Series A

Versant Ventures established Helicore Biopharma exactly two months after...

Research & Development

Sionna Therapeutics Targets $156 Million in IPO to Advance Cystic Fibrosis Research

Sionna Therapeutics, a biotechnology firm headquartered in Waltham, Massachusetts, is preparing to raise up...

Oculis’ Phase 2 Study Explores OCS-05 for Optic Nerve Inflammation

A phase 2 clinical trial has assessed the effectiveness and safety of OCS-05, a...

Research finds Merck’s treatment of lung disease can lower chance of death

Merck has released that its drug, Winrevair, reduced the risk of death in patients...

GSK Responds to Pfizer’s RSV Approval with Data Aiming for Similar Approval in Younger Adults

Two early-phase study trials suggest that GSK’s RSV vaccine, Arexvy, may benefit certain high-risk...

Market Access

Failed facility inspection by partners places Atara’s Ebvallo pipeline candidate on clinical hold in the United States

Atara Biotherapeutics has now faced a second setback after getting a complete response from...

Novo Nordisk Planning Huge $4.1B Plant in NC For Ozempic Production

It seems like GLP-1 giants Novo Nordisk and Eli Lilly are locked in a...

French Company Orano Med Opens New Radiation Production Facility Near Indianapolis

In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as...

Gerresheimer Increases the Capabilities of Medical Systems in the USA

Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma,...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Sionna Therapeutics Targets $156 Million in IPO to Advance Cystic Fibrosis Research

Sionna Therapeutics, a biotechnology firm headquartered in Waltham, Massachusetts,...

Novo Nordisk Planning Huge $4.1B Plant in NC For Ozempic Production

It seems like GLP-1 giants Novo Nordisk and Eli...

Atalanta Therapeutics Secures $97 Million to Advance siRNA Therapies for Neurological Disorders

Atalanta Therapeutics has raised $97 million in a successful...